Your browser is no longer supported. Please, upgrade your browser.
Orgenesis Inc.
Index- P/E- EPS (ttm)-2.69 Insider Own5.46% Shs Outstand24.27M Perf Week8.36%
Market Cap88.02M Forward P/E- EPS next Y-0.19 Insider Trans0.00% Shs Float22.31M Perf Month-23.06%
Income-64.50M PEG- EPS next Q0.08 Inst Own18.50% Short Float1.13% Perf Quarter-34.94%
Sales30.90M P/S2.85 EPS this Y-215.50% Inst Trans-7.15% Short Ratio3.91 Perf Half Y-39.50%
Book/sh1.78 P/B1.89 EPS next Y-110.50% ROA-86.00% Target Price9.00 Perf Year-26.10%
Cash/sh0.57 P/C5.91 EPS next 5Y- ROE-128.30% 52W Range2.88 - 8.30 Perf YTD-25.11%
Dividend- P/FCF- EPS past 5Y-27.90% ROI-147.10% 52W High-59.40% Beta1.22
Dividend %- Quick Ratio2.70 Sales past 5Y3.60% Gross Margin- 52W Low17.01% ATR0.26
Employees111 Current Ratio2.70 Sales Q/Q411.80% Oper. Margin- RSI (14)39.65 Volatility7.90% 7.31%
OptionableYes Debt/Eq0.27 EPS Q/Q3.30% Profit Margin- Rel Volume1.40 Prev Close3.32
ShortableYes LT Debt/Eq0.17 EarningsNov 04 BMO Payout- Avg Volume64.42K Price3.37
Recom2.00 SMA20-5.36% SMA50-21.26% SMA200-33.80% Volume88,833 Change1.51%
Dec-20-18Initiated Dawson James Buy
Nov-29-21 07:00AM  
Nov-15-21 07:00AM  
Nov-04-21 07:30AM  
Nov-02-21 09:00AM  
Aug-23-21 08:00AM  
Aug-16-21 08:30AM  
Aug-12-21 08:30AM  
Aug-05-21 07:00AM  
Aug-03-21 08:30AM  
Jul-26-21 07:56AM  
Jul-06-21 07:00AM  
Jun-15-21 03:23PM  
Jun-10-21 07:00AM  
Jun-01-21 07:30AM  
May-27-21 07:15PM  
May-07-21 07:00AM  
May-06-21 07:30AM  
May-05-21 07:30AM  
Mar-29-21 07:00AM  
Mar-18-21 07:00AM  
Mar-11-21 07:00AM  
Mar-09-21 08:08AM  
Mar-08-21 07:30AM  
Mar-04-21 11:15AM  
Feb-16-21 07:00AM  
Jan-25-21 06:13AM  
Nov-05-20 08:30AM  
Nov-03-20 03:15PM  
Oct-26-20 01:53PM  
Oct-19-20 06:30AM  
Sep-29-20 06:30AM  
Sep-09-20 07:00AM  
Aug-20-20 07:30AM  
Aug-07-20 07:30AM  
Aug-06-20 03:32PM  
Jul-14-20 01:19PM  
Jun-29-20 08:00AM  
Jun-22-20 08:00AM  
Jun-10-20 09:07AM  
Jun-01-20 09:38AM  
May-22-20 09:11AM  
May-15-20 07:30AM  
May-13-20 02:20PM  
May-11-20 07:30AM  
Apr-29-20 10:32AM  
Apr-27-20 07:30AM  
Apr-15-20 08:50AM  
Apr-13-20 07:45AM  
Apr-08-20 11:52AM  
Mar-31-20 07:30AM  
Mar-30-20 07:30AM  
Mar-10-20 07:30AM  
Mar-09-20 03:46PM  
Feb-19-20 06:00AM  
Feb-11-20 08:00AM  
Feb-04-20 07:51AM  
Feb-03-20 07:35AM  
Jan-21-20 07:00AM  
Jan-13-20 09:25AM  
Jan-10-20 07:00AM  
Dec-23-19 12:25PM  
Dec-11-19 09:49AM  
Dec-06-19 08:53AM  
Nov-26-19 07:00AM  
Nov-22-19 12:20PM  
Nov-13-19 07:00AM  
Nov-08-19 07:00AM  
Oct-31-19 09:14AM  
Oct-28-19 07:00AM  
Oct-16-19 07:00AM  
Sep-10-19 08:35AM  
Sep-09-19 10:36AM  
Aug-14-19 08:30AM  
Aug-12-19 08:30AM  
Jun-17-19 08:41AM  
May-09-19 09:00AM  
Apr-30-19 09:00AM  
Apr-24-19 11:01AM  
Apr-23-19 08:30AM  
Apr-22-19 09:00AM  
Apr-11-19 09:00AM  
Apr-08-19 10:30AM  
Apr-04-19 09:42AM  
Apr-03-19 09:00AM  
Mar-28-19 09:00AM  
Mar-27-19 08:30AM  
Mar-25-19 09:18AM  
Mar-07-19 11:31AM  
Feb-14-19 08:44AM  
Feb-11-19 08:30AM  
Feb-06-19 08:30AM  
Feb-05-19 08:30AM  
Jan-25-19 08:30AM  
Jan-22-19 04:00PM  
Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. sThe company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. The company was incorporated in 2008 and is based in Germantown, Maryland.